Baker Avenue Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-579
Closed -$31.1K – 1314
2023
Q3
$31.1K Sell
579
-58
-9% -$3.09K ﹤0.01% 587
2023
Q2
$34.4K Sell
637
-59
-8% -$3.17K ﹤0.01% 574
2023
Q1
$37.9K Buy
696
+41
+6% +$1.99K ﹤0.01% 573
2022
Q4
$31.7K Buy
+655
New +$28.8K ﹤0.01% 549

Other funds holding SNY

Baker Avenue Asset Management's SNY Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of Sanofi (SNY) in Q4 2023, closing a stake of 579 shares — an estimated $31.1K sold.

Baker Avenue Asset Management first reported a position in SNY in Q4 2022 and held it in 4 quarters. The position peaked at $37.9K in Q1 2023. 709 funds tracked by Wall St. Rank hold SNY as of Q4 2023.

  • Baker Avenue Asset Management reported no remaining Sanofi position as of Q4 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 579 Sanofi shares in Q4 2023, an estimated $31.1K.
  • Baker Avenue Asset Management first reported a position in Sanofi in Q4 2022 and held it in 4 quarters.
  • Baker Avenue Asset Management's Sanofi position peaked at $37.9K in Q1 2023.
  • 709 funds tracked by Wall St. Rank held Sanofi as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.